BRIDGEWATER, N.J., November 21, 2024--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company"), a global pharmaceutical company, today ...

HUNTSVILLE, Ala. (WAFF) - There is now an FDA-approved alternative to the EpiPen. A new nasal spray, called Neffy, can be used by people to treat severe allergic reactions. The new spray has ...

HUNTSVILLE, Ala. (WAFF) - There is now an FDA-approved alternative to the EpiPen. A new nasal spray, called Neffy, can be used by people to treat severe allergic reactions. The new spray has already ...

Amneal Pharmaceuticals (AMRX) announced the advancement of two key strategic initiatives. First, the Company has resubmitted to the U.S. Food and Drug Administration (FDA) its new drug application ...